Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and ...

Nucleome is using breakthrough genomics technologies to discover first-in-class antibody therapeutics for inflammatory diseases. The approach is based solely on human disease genetics and biology.

Genomics company Pacific Biosciences of California (NASDAQ:PACB) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 3.8% year on year to $38.44 million. Its non-GAAP loss of $0 ...

A new method vastly improves on the existing approach for single-cell genetic sequencing, enabling scientists to read the ...

Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...

GENETIC interactions between humans and mycobacterium tuberculosis (M.tb), the bacterium that causes tuberculosis (TB), is ...

The study showcases an innovative and effective approach for large-scale genomic research of individual cells and viral ...

X Health (USA) and REVIV Global (UK) today announced a strategic partnership with M42, a global health leader powered by ...

The MARBLES team is excited to share a new breakthrough from the project! The study led by the University of Aberdeen and ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.